By Tokio X'press flu, Product Safety & Quality, Responsible Investment, Access to Health Care, Drugs, Pharmaceutical
COVID-19:スコットランドでファビピラビルの治験:NHS:(動画): Investigate Favipiravir as Onset Treat for Mild to Moderate in Scotland: NHS研究Favipiravir作为苏格兰轻度至中度COVID-19的早期发作治疗
COVID-19: Appili、米国でファビピラビル治験:第3相試験募集(動画): Appili Provides Enrollment Update for Phase 3 PRESECO Trial Favipiravir: Appili Therapeutics提供了其PRESECO第三阶段试验的注册更新
COVID-19:Dr. Reddy’s、クウェートでAVIGAN治験終了:感染初期に(動画): COVID-19: Dr. Reddy ’s AVIGAN trial in Kuwait: in early infection: COVID-19:Reddy博士在科威特完成AVIGAN试验:早期感染的治疗作用
COVID-19:ノーベル賞のイベルメクチン:致死率80%減少の効果(動画): COVID-19: Nobel Prize Ivermectin: Reducing case fatality rate by 80%: COVID-19:诺贝尔奖伊贝菌素:将致死率降低80%的效果
COVID-19:日本当局がアビガンの承認を見送り:継続審議(動画): COVID-19: Authorities postpone approval of Avigan:continued deliberation: COVID-19:日本当局推迟批准Avigan:继续进行审议